Eledon Pharmaceuticals, Inc. - Common Stock — Liquidità Trimestrale (NASDAQ:ELDN)

Financials

Totale attivo 177.41 M161.31 M144.91 M129.86 M169.01 M146.67 M Totale passività 59.27 M46.73 M38.88 M38.8 M32.23 M46.21 M Patrimonio netto totale 118.14 M114.58 M50.33 M35.36 M81.08 M44.76 M Totale passività e patrimonio netto 177.41 M161.31 M144.91 M129.86 M169.01 M146.67 M Debito totale —————— Indebitamento netto ——————

Notizie

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

Eledon presenterà i dati del trial su trapianto renale a una conferenza

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - NewcelX (NASDAQ:NCEL)

NewcelX aggiorna la presentazione sulla collaborazione per la terapia del diabete

Leerink Partners conferma rating Outperform su Eledon a $5

Leerink Partners reiterates Outperform on Eledon stock at $5

Eledon reports insulin independence in islet transplant trial

NewcelX collabora con Eledon per terapia diabete tipo 1

NewcelX partners with Eledon on type 1 diabetes therapy

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon riporta dati positivi a 24 mesi sul trapianto di rene per tegoprubart

Eledon reports positive 24-month kidney transplant data for tegoprubart